605627-17-6 Usage
Chemical structure
A benzoxazolyl derivative with a piperidine carboxamide core and a 2-methoxyphenyl group attached to the nitrogen atom.
Classification
A selective 5-HT4 agonist, which means it specifically activates serotonin 5-HT4 receptors.
Therapeutic applications
Potential treatment for gastrointestinal disorders, Alzheimer's disease, and schizophrenia.
Additional properties
Neuroprotective and anti-inflammatory effects have been observed in preclinical studies.
Current status
BIMU-8 has shown promise in preclinical studies, but further research is needed to determine its safety and efficacy for use in human medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 605627-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,5,6,2 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 605627-17:
(8*6)+(7*0)+(6*5)+(5*6)+(4*2)+(3*7)+(2*1)+(1*7)=146
146 % 10 = 6
So 605627-17-6 is a valid CAS Registry Number.